A monoclonal antibody agsinst anti-muller ian hormone Anti-mullerian hormone (AHH) has been partially purified from incUbation medium of calf fetal testes (Picard and Josso. 1981). It produces muller ian regression in organ culture and contains one major radioactive protein, when testes have been incubated in the presence of tritiated fucose . Identity between AHH and this labelled marker protein has been postulated, and, in consequence, the latter has been used to screen hybridomas for anti-AHH activity. Splenocytes of a BALB/c mouse, injected with partially purified AHH, produced 297 hybridomas after fusion with myeloma cells . Culture medium from 94 was tested. in a doUble antibody precipitation test , for its capacity to bind the labelled protein contained in partially purified medium. Three IgG hybridomas gave ·pos i t i ve results and one vas cloned and used to produce ascites in BALB/c mice. Ascites IgG, used as first antibody in a dotble antibody precipitation test, precipitated the labelled protein and removed anti-mullerian activity from medium containing bioactive AHH. The monoclonal antibody also blocked anti-mUllerian activity of calf fetal testicular tissue. indicating that it is directed against the b iologically active port ion of the AHH molecule. These results prove the identity between AHH and its biochemical marker, and should greatly hasten the isolation and quantitative assay of t he hormone. 24 h 6 42.7
We have detected 3 variant polymorphic Bgl II restriction patterns which are traceable through pedigrees and can be used to test for physical linkage of HGH deficiency to HGH/HPL gene cluster variation. All HGH/HPL restriction patterns found in hypopituitary individuals were also found in normals. Thus. there were no instances in which HGH deficiency could be attributed to deletion of an HGH gene. Also. discordance for Bgl II reatriction patterns in 2 siblings with autosomal recessive HGH deficiency provided evidence against HGH gene mutation as the cause of the disease.
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F.J.HOLLAND, D.DiBATTISTA-and L.LUNA* Hospital for Sick Children, U of Tbronto,Canada So1ll8tomedin in the rhesus monkey fe tus To assess the role of s01ll8tomedin in the 1Il8turing fetus, a RIA was developed for Multiplication Stimulating Activity (MSA). a major s01ll8tomedin. Purified liSA was conjugated to hemocyanin and specific antiserum induced in rabbits. In the RIA there waa parallel diaplacement with unlabelled liSA and acid-extracted human or rhesus monkey serum. There was no cross-resctivity with phyaiological concentrations of insulin or with the other somatomedins. Immunoreactive MSA(I-MSA) in acromegalic serum extracts was approximately twice that of normal controls, while levels were reduced in growth hormone (GH) deficiency. I-liSA in pooled extracts from sera of 5 adult male monkeys was 84.0 ng/mI. Fetal samples were obtained from rhesus monkeys through catheterized interplacental vessels. At 90 days gestation (term 165 days). Ontogenes is of so matogeni c a nd lactogeni c l i ve r receptors 1n male and f emal e r a t s.
To stud y t he r egulatio n of t he li ver somatogenic [GH) and lact oge ni c (PRLl r eceptors dur ing de velopment. t hei r number and affinity were det ermined at weekly intervals in male a nd female rats. the results were correlated with gr owt h ve l oc ity and the hormonal changes indu ced by puberty. The GH and PRL binding sites of liver homogenates were ana lyzed using 125I-bovlne and 125I-ov1ne PRL.
In the males. the PRL receptor s were present at day 21 (2.0±D.5 pmoles/liver, mean±1 S.E •• n=5l . reached a peak at day 35 (9±2. n=51. then de creased to be undetectable at day 63 . In the females. their evolution was similar unt il day 35, thereaft er. a four-fold i ncrease occurred. a plateau being rea ched at day 49 (52±8, n-51.
The number of GH r eceptors exhibited a progregsive increase 1n male s (day 21: 9±1, n=5. da y 120: 47±9 . n=51 and females (day 21 : 5±1.n=5, da y 120 : 73±10.n= 51. At t he time of pUbertal growth spurt th e mean numb er of GH receptors was equal to 50\ of t he adult valu es. The aff inity (Ka) of GH and PRL receptors showed no significa nt change with age a nd se x (bGH: D.6 1±0 .0 3x10 9 M-I, oPRL: 0.93± 0. 06x10 9 M-1 ,n -601. Thes e da t a sugges t t hat in the male. t he pUbertal rise of t estosterone inhibi ts th e PRL receptors. while in the f emale the s u r ge of estradiol induce s a sharp increase of these receptors. The GH receptors do not appear to be regulated by gonadal steroids. Serum ICF levels were assayed, after acid extraction, in 26 girls and 32 boys (aged 1 -22) whose height for their age exceed) SO, by a radioligand assay using human IeF (gift from Dr Zapf , ZUrich) and a specific binding proteIn produced by rat lIver In culture. Results are expressed In relatIon to a pool of normal adult serum arbitrarily assigned a value of 1 U/ml. 1) For the 15 children aged 1-10, the mean ICF level was 0.8)~0.09 (SEM) U/ml which is significantly hIgher than that for normal children (0.59 ! 0.05, n =29) (p <0.01) . 2) In the 21 10.15 year-old, ICF levels (1.)5 ! 0.09) were higher than controls (1.05~0.08, n =16) (p< 0.01). 7 girls and 1 boy had levels (1.52 -2.46) comparable to those of untreated acromegalies. CH levels 60 min after glucose load ()O g/m 2 ) were < 5 ng/ml in 11 subjects studied. ) In the 22 patIents over 15, IeF levels (1.09 t 0.07) were silll1lar to those of normal adults (1.0/ : 0.03 U/ml). 4) In 10 girls under etlinyloestradiol (200·300 fg/daf or a prognosis of a final height exceeding 180 em, parallel with the decrease in growth, there was a slow but progressive drop in ICF levels (means: 1.49 U/ml after) months. 1.06 after 1 year). The abnormally high ICF levels seen wIth idiopathic tall stature and the drop accompanying oestrogen therapy suggest a dIrect relation between ICF production and growth rate . The return to normal levels once ossification is complete suggests a regulatory disorder durinq the growth period.
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